![Didier Coquoz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Didier Coquoz is the founder of BioLingus (Cayman) Ltd., founded in 2018.
Former job includes Chief Development Officer at Cytune Pharma SAS. Education includes graduate degree from the University of Geneva.
| Sociétés | Poste | Fin |
|---|---|---|
Cytune Pharma SAS
 Cytune Pharma SAS Miscellaneous Commercial ServicesCommercial Services Develops immunotherapeutic agents to treat primarily cancer | Corporate Officer/Principal | 01/12/2014 |
BioLingus (Cayman) Ltd.
 BioLingus (Cayman) Ltd. BiotechnologyHealth Technology Develops oral and mucosal delivery of peptides & proteins for chronic diseases | Fondateur | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 3 |
|---|---|
University of Geneva
 University of Geneva Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cytune Pharma SAS
Cytune Pharma SAS Miscellaneous Commercial ServicesCommercial Services Develops immunotherapeutic agents to treat primarily cancer | Commercial Services |
BioLingus (Cayman) Ltd.
BioLingus (Cayman) Ltd. BiotechnologyHealth Technology Develops oral and mucosal delivery of peptides & proteins for chronic diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
